Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria J Merino

Showing results (71-80 of 296) with videos related to

Pageof 30
Sort By:
American Journal of Clinical Oncology|January 31, 2020
Twenty-five-Year Follow-up of a Prospective Randomized Trial Comparing Preoperative Versus Postoperative FLAC/Granulocyte Colony-Stimulating Factor Chemotherapy for Stage II Breast CancerParisa Malekzadeh, Kenneth Cowan, Seth M Steinberg, et al.
Abdominal Radiology (New York)|November 27, 2025
Birt-Hogg-Dubé: CT characteristics of renal tumors in a rare syndromeMahshid Golagha, Negin Jarrah, Shiva Singh, et al.
Breast Cancer Research and Treatment|September 27, 2014
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007Kathy D Miller, Sandra K Althouse, Lisle Nabell, et al.
Urologic Oncology|December 27, 2008
Immunohistochemical basis for adjuvant anti-angiogenic targeted therapy for renal carcinoid: initial case reportDavid S Finley, Navneet Narula, Vladimir A Valera, et al.
Abdominal Radiology (New York)|March 27, 2020
Impact of bowel preparation with Fleet's™ enema on prostate MRI qualityMehmet Coskun, Sherif Mehralivand, Joanna H Shih, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 14, 2002
Successful outcome after surgical management in two cases of the "painful variant" of Hashimoto's thyroiditisLoukas Gourgiotis, Nahrain Al-Zubaidi, Monica C Skarulis, et al.
Endocrinology, Diabetes & Metabolism Case Reports|January 10, 2020
Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemmaImpana Shetty, Sarah Fuller, Margarita Raygada, et al.
Molecular Cancer|June 25, 2010
Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signalingSeung-Beom Hong, HyoungBin Oh, Vladimir A Valera, et al.
Genes, Chromosomes & Cancer|February 15, 2017
Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinomaCathy D Vocke, Christopher J Ricketts, Maria J Merino, et al.
Hepato-Gastroenterology|May 17, 2003
3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasiaJulian Sanz-Ortega, Susana Hernández, Maria C Saez, et al.
Pageof 30

Showing results (71-80 of 296) with videos related to

Sort By:
Pageof 30
American Journal of Clinical Oncology|January 31, 2020
Twenty-five-Year Follow-up of a Prospective Randomized Trial Comparing Preoperative Versus Postoperative FLAC/Granulocyte Colony-Stimulating Factor Chemotherapy for Stage II Breast CancerParisa Malekzadeh, Kenneth Cowan, Seth M Steinberg, et al.
Abdominal Radiology (New York)|November 27, 2025
Birt-Hogg-Dubé: CT characteristics of renal tumors in a rare syndromeMahshid Golagha, Negin Jarrah, Shiva Singh, et al.
Breast Cancer Research and Treatment|September 27, 2014
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007Kathy D Miller, Sandra K Althouse, Lisle Nabell, et al.
Urologic Oncology|December 27, 2008
Immunohistochemical basis for adjuvant anti-angiogenic targeted therapy for renal carcinoid: initial case reportDavid S Finley, Navneet Narula, Vladimir A Valera, et al.
Abdominal Radiology (New York)|March 27, 2020
Impact of bowel preparation with Fleet's™ enema on prostate MRI qualityMehmet Coskun, Sherif Mehralivand, Joanna H Shih, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 14, 2002
Successful outcome after surgical management in two cases of the "painful variant" of Hashimoto's thyroiditisLoukas Gourgiotis, Nahrain Al-Zubaidi, Monica C Skarulis, et al.
Endocrinology, Diabetes & Metabolism Case Reports|January 10, 2020
Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemmaImpana Shetty, Sarah Fuller, Margarita Raygada, et al.
Molecular Cancer|June 25, 2010
Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-beta signalingSeung-Beom Hong, HyoungBin Oh, Vladimir A Valera, et al.
Genes, Chromosomes & Cancer|February 15, 2017
Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinomaCathy D Vocke, Christopher J Ricketts, Maria J Merino, et al.
Hepato-Gastroenterology|May 17, 2003
3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with a high risk of developing adenocarcinoma in Barrett's epithelium without dysplasiaJulian Sanz-Ortega, Susana Hernández, Maria C Saez, et al.
Pageof 30